Krystal Biotech Inc.

NASDAQ: KRYS · Real-Time Price · USD
150.42
0.09 (0.06%)
At close: Aug 15, 2025, 3:59 PM
147.27
-2.09%
After-hours: Aug 15, 2025, 07:11 PM EDT

Krystal Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
96.04M 88.18M 91.14M 83.84M 70.28M 45.25M 42.14M 8.56M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 5.03M 4.95M 6.68M 8M 2.42M 4.38M 223K 1.2M n/a 1.09M 975K 976K 1.01M 784K 783K 665K 536K
Gross Profit
87.33M 83.16M 86.19M 77.16M 62.29M 42.83M 37.77M 8.33M -1.2M n/a -1.09M -975K -976K -1.01M -784K -783K -665K -536K
Operating Income
39.31M 36.18M 41.38M 22.43M 21.07M -6.68M 3.14M -25.99M -38.05M -48.82M -34.77M -31.45M -28.75M -50.22M -21.88M -15.65M -16.39M -14.35M
Interest Income
n/a n/a 7.23M n/a 7.48M 7.62M 7.52M 6.74M 4.84M 3.53M 2.72M 1.6M 645K 257K 70K 63K 30K 33K
Pretax Income
46.77M 43.6M 48.61M 29.77M 16.05M 932K 10.66M 80.75M -33.21M -45.3M -32.05M -29.85M -28.11M -49.97M -21.81M -15.59M -16.36M -15.81M
Net Income
38.33M 35.73M 45.48M 27.18M 15.57M 932K 8.69M 80.75M -33.21M -45.3M -32.05M -29.85M -28.11M -49.97M -21.81M -15.59M -16.36M -15.81M
Selling & General & Admin
35.16M 32.72M 31.29M 28.71M 25.64M 26.06M 23.26M 23.7M 25.9M 24.04M 24.03M 19.93M 17.86M 15.91M 12.87M 9.57M 9.8M 8.15M
Research & Development
14.41M 14.26M 13.52M 13.51M 15.58M 10.96M 11.37M 10.63M 12.14M 12.29M 10.74M 11.52M 10.89M 9.31M 9.01M 6.08M 6.59M 6.2M
Other Expenses
7.17M n/a n/a 12.5M n/a n/a n/a 223K n/a 12.5M 25M n/a n/a 25M n/a n/a n/a n/a
Operating Expenses
56.73M 46.98M 44.81M 54.72M 41.22M 37.02M 34.63M 34.55M 38.05M 48.82M 34.77M 31.45M 28.75M 25.22M 21.88M 15.65M 16.39M 14.35M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 257K n/a n/a n/a 1.49M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -50.38M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 52.01M 49.76M 61.41M 49.22M 39.43M 39.01M 34.55M 38.05M 48.82M 34.77M 31.45M 28.75M 25.22M 21.88M 15.65M 16.39M 14.35M
Income Tax Expense
-8.44M 7.86M 3.13M 2.59M 477K 4.88M 1.97M n/a n/a n/a n/a n/a n/a n/a 71K 63K 31K 33K
Shares Outstanding (Basic)
28.91M 28.82M 28.75M 28.72M 28.6M 28.3M 28.17M 28.04M 26.66M 25.71M 25.68M 25.62M 25.55M 25.11M 22.95M 22.21M 22.2M 21.25M
Shares Outstanding (Diluted)
29.75M 29.87M 29.88M 29.9M 29.64M 29.29M 28.82M 28.89M 26.66M 25.71M 25.68M 25.62M 25.55M 25.11M 23.11M 22.21M 22.2M 21.25M
EPS (Basic)
1.33 1.24 1.58 0.95 0.54 0.03 0.31 2.88 -1.25 -1.76 -1.25 -1.17 -1.1 -1.99 -0.95 -0.7 -0.74 -0.74
EPS (Diluted)
1.29 1.20 1.52 0.91 0.53 0.03 0.30 2.79 -1.25 -1.76 -1.25 -1.17 -1.1 -1.99 -0.94 -0.7 -0.74 -0.74
EBITDA
39.31M 37.81M 42.93M 31.26M 18.03M 2.54M 12.16M -25.99M -38.05M -35.01M -30.96M -30.48M -27.78M -24.21M -21.02M -14.81M -15.7M -14.35M
EBIT
46.77M 36.18M 41.38M 29.77M 16.05M 5.82M 10.66M -25.99M -38.05M -36.32M -32.05M -29.85M -28.11M -25.22M -21.81M -15.59M -16.36M -14.32M
Depreciation & Amortization
n/a 1.63M 1.59M 1.53M 1.99M 1.61M 1.51M 1.2M 1.2M 1.31M 1.09M 975K 976K 1.01M 784K 783K 665K 536K